達諾生技股份有限公司
深海高純度魚油保健食品 | 達諾生技股份有限公司

FDA approves use of drug to reduce risk of cardiovascular events in certain adult patient groups (December 13, 2019)

日期:2020-05-04

文章引用自:https://bit.ly/2X5Qlws

 
The U.S. Food and Drug Administration today approved the use of Vascepa (icosapent ethyl) as an adjunctive (secondary) therapy to reduce the risk of cardiovascular events among adults with elevated triglyceride levels (a type of fat in the blood) of 150 milligrams per deciliter or higher. Vascepa is the first FDA approved drug to reduce cardiovascular risk among patients with elevated triglyceride levels as an add-on to maximally tolerated statin therapy.
TOP

2020© Copyright All Rights Reserved

蘋果網頁設計
高純度魚油不花大錢,就能買到魚油保健養生食品,讓你大呼好便宜!研究發現其能顯著降低甘油三酯,魚油保健食品同時可降低總膽固醇、低密度脂蛋白膽固醇、高純度魚油極低密度脂蛋白膽同醇和升高高密度脂蛋白膽固醇。魚油保健食品防治冠心病、深海魚油促進腦、視網膜發育、魚油保健食品增進免疫調節、幫助對抗炎症、深海魚油抗癌功效、改善不良情緒。高純度魚油促進脂肪酸的氧化,深海魚油增強脂肪酸向磷脂的轉化。